Emry v. United States

829 A.2d 970, 2003 D.C. App. LEXIS 530, 2003 WL 21939722
CourtDistrict of Columbia Court of Appeals
DecidedAugust 14, 2003
Docket00-CM-154, 01-CO-661
StatusPublished
Cited by1 cases

This text of 829 A.2d 970 (Emry v. United States) is published on Counsel Stack Legal Research, covering District of Columbia Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Emry v. United States, 829 A.2d 970, 2003 D.C. App. LEXIS 530, 2003 WL 21939722 (D.C. 2003).

Opinion

REID, Associate Judge.

On January 28, 2000, appellant, Ms. Renee Emry, was convicted of unlawful possession of marijuana in violation of D.C.Code § 3S-541(d) (1998). 1 On appeal she challenges the trial court’s rejection of her medical necessity defense. We affirm, and hold that on the facts of this case, Ms. Emry failed to establish a case of medical necessity.

FACTUAL SUMMARY

On September 15, 1998, at around 9:18 in the morning, Ms. Emry, a Michigan resident, entered the United States Capitol office of Representative William McCol-lum, a member of Congress from the State of Florida, and began smoking marijuana. She appeared “wobbly” and held a banner which read: “I use marijuana for multiple *972 sclerosis.” Officers with the United States Capitol Police responded to the scene and arrested her.

At trial the defense claimed that it was medically necessary for Ms. Emry to use the marijuana because of her multiple sclerosis, and presented Dr. Denis Petro, an expert in neurology and pharmacology, as its only witness. 2 He examined Ms. Emry after her arrest and confirmed upon reviewing her medical records 3 that she suffered from multiple sclerosis and experienced spasticity as a result — a symptom involving painful, uncontrollable muscle spasms. Several drugs are generally prescribed to treat the condition, including Baclofen, Dantrium, Valium, and marijuana. Ms. Emry has used marijuana and Baclofen to control the symptoms of her illness.

The trial court ruled that the evidence presented by Ms. Emry was insufficient to permit a necessity defense because it did not satisfy the factors set forth in Griffin v. United States, 447 A.2d 776 (D.C.1982). Specifically, it determined that Ms. Emry had legal alternatives besides using marijuana to treat her spasticity. It further found that she was not in imminent danger of experiencing spasticity at the time she smoked marijuana in the congressman’s office, and that Ms. Emry’s use of marijuana was not designed to avert an attack of spasticity.

ANALYSIS

Ms. Emry contends that the trial court erred in failing to follow the principles set forth in United States v. Randall, 104 Daily Wash. L. Rpth. 2249 (D.C.Super.Ct. December 28, 1976), which recognized the use of a medical necessity defense to the illegal possession of marijuana. She claims that the Superior Court’s decision in that case “has been explicitly accepted by this Court as precedent” and thus she should have been permitted to raise a medical necessity defense to her criminal charge.

However, we have not adopted Randall’ s holding, nor do we decide on this record whether medical necessity can ever be a defense to the unlawful possession of marijuana. Even assuming such a defense exists in this jurisdiction, the facts presented here are insufficient to support its application.

In Griffin, supra, which involved a claim that the charged unlawful entry of a church was “necessary” to call attention to the plight of homeless persons, we explained that “the necessity defense exonerates persons who commit a crime under the ‘pressure of circumstances,’ if the harm that would have resulted from compliance with the law would have significantly exceeded the harm actually resulting from the defendants’ breach of the law.” Id. at 777 (citing Randall, supra, 104 Daily Wash. L. Rptr. at 2249) (other citations omitted). But, we made clear that

[t]he defense is not available where: (1) there is a legal alternative available to the defendant] that does not involve violation of the law; (2) the harm to be prevented is neither imminent, nor would be directly affected by the defendantPs] actions; and (3) the de-fendantPs] actions were not reasonably designed to actually prevent the threatened greater harm.

*973 Id. at 778 (internal citations omitted). In other words, “ ‘if there was a reasonable legal alternative to violating the law, a chance both to refuse to do the criminal act and also to avoid the threatened harm, the [necessity] defens[e] will fail.’ ” Id. at 778 (quoting United States v. Bailey, 444 U.S. 394, 410, 100 S.Ct. 624, 62 L.Ed.2d 575 (1980)) (internal quotation marks and other citation omitted). Moreover, since necessity is an affirmative defense, the burden was on Ms. Emry to put forth sufficient evidence to satisfy the Griffin factors. See also United States v. Unser, 165 F.3d 755, 764 (10th Cir.1999) (“[T]he defendant ... must bear the initial burden of producing evidence which could support a finding in h[er] favor on each element of the defense”). But Ms. Emry did not meet her burden.

Here, Dr. Petro, the only witness who testified on behalf of the defense, acknowledged that Ms. Emry had legal alternatives to treat spasticity other than smoking marijuana. According to him, there are three drugs that are specifically marketed for the treatment of the condition, namely Baclofen, Dantrium, and Zanaflex, and at least thirty others that may be prescribed for the same purpose. Ms. Emry at one point used Baclofen “but was not able to tolerate it.” However, the record does not indicate that she tried Dantrium or Zana-flex. Furthermore, Dr. Petro acknowledged that Valium, a muscle relaxant, can be obtained legally and is prescribed to treat spasticity. But the record does not indicate that Ms. Emry ever tried that drug or any of the dozens of other drugs used to alleviate her condition.

At one point, Dr. Petro noted that “[t]here is no drug [that is] without side [e]ffects.” And he pointed out that while Baclofen is “[t]he most common drug right now in the United States” for treatment of spasticity, its side effects included mood swings, “dizziness or nausea or vomiting .... ” Also, Dantrium is known to have “very high [ ]toxicity” levels and Zanaflex has a “very poor efficacy” rate. However, Dr. Petro acknowledged that smoking marijuana can cause adverse effects on the heart. And, more importantly, although Dr. Petro testified that the use of marijuana eased Ms. Emry’s spasticity attacks, he also acknowledged that her medical records indicated that Dr. Selwa had “concluded that there was no way to objectively document clear differences [in her condition when she was] on or off [of marijuana].” Furthermore, the record does not indicate that Ms. Emry was in “imminent” harm of experiencing an attack of spasticity at the moment she smoked marijuana in Congressman McCollum’s office, nor that her use of marijuana at that particular time would have affected her condition. In addition, the record does not show that her actions were “reasonably designed to actually prevent” such an attack.

Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jefferson v. State
883 A.2d 251 (Court of Special Appeals of Maryland, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
829 A.2d 970, 2003 D.C. App. LEXIS 530, 2003 WL 21939722, Counsel Stack Legal Research, https://law.counselstack.com/opinion/emry-v-united-states-dc-2003.